| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 03/01/2006 | EP1628619A2 4-aminopyrimidine-5-one |
| 03/01/2006 | CN1742013A Pyrazolopyrimidine compound and method for producing the same |
| 03/01/2006 | CN1742000A Process for the preparation of rosuvastatin |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 03/01/2006 | CN1243545C DNA-cleaving antitumor agents |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/24/2006 | CA2533320A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2006 | WO2006018284A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | WO2005118557A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/23/2006 | WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors |
| 02/23/2006 | US20060041132 Novel triazolo pyrimidine compounds |
| 02/23/2006 | US20060041130 Syntheses of quinazolinones |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060041126 Electroluminescent device |
| 02/23/2006 | US20060041024 Polycationic compounds and uses thereof |
| 02/23/2006 | US20060040968 2-(Amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 02/23/2006 | US20060040955 4-pyrimidineamine compounds and their uses as anti-proliferative agents |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | CA2576993A1 Bisaryl-sulfonamides |
| 02/23/2006 | CA2575826A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | CA2575188A1 Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
| 02/23/2006 | CA2575056A1 Selected fused heterocyclics and uses thereof |
| 02/22/2006 | EP1626725A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 02/22/2006 | EP1626716A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1243002C Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultural/horticultural bactericides |
| 02/22/2006 | CN1242993C Heterocycle derivatives and drugs |
| 02/22/2006 | CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 02/21/2006 | US7001887 Peptide derivatives |
| 02/21/2006 | US7001647 can be mixed with nematic liquid crystal material to provide liquid crystal composition having low viscosity, low refractive index anisotropy ( Delta n), high dielectric anisotropy ( Delta epsilon ), and high NI point ( broad nematic phase range) |
| 02/21/2006 | CA2309340C Pyrimidine derivatives for labeled binding partners |
| 02/16/2006 | WO2006017844A1 NOVEL 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) |
| 02/16/2006 | WO2006017836A2 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace) |
| 02/16/2006 | WO2006017822A2 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 02/16/2006 | WO2006017208A1 Mass tags for quantitative analyses |
| 02/16/2006 | WO2006016014A1 Novel compounds of a 6-methyl-pyrimidine-2,4-diamine family, method for synthesising, compositions containing said compounds and the use thereof |
| 02/16/2006 | WO2006015859A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/16/2006 | WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 02/16/2006 | WO2005097137A3 Advanced quinazoline based protein kinase inhibitors |
| 02/16/2006 | WO2005080352A3 Quinazoline derivatives and therapeutic use thereof |
| 02/16/2006 | US20060036093 Pyrimidinone compounds |
| 02/16/2006 | US20060036092 making 4(R)-[-2,6-diamino-purin-9-yl)-[1,3]-dioxolan-2(R)-yl]-methanol ( beta -D-DAPD); esterification, cyclization, selective reduction, purification |
| 02/16/2006 | US20060035938 2-Pyridone derivatives as inhibitors of neutrophile elastase |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035913 Method for the production of 2-amino-4-chloro-6-alkoxypyrimidines |
| 02/16/2006 | US20060035909 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout |
| 02/16/2006 | US20060035897 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/16/2006 | US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
| 02/16/2006 | DE102004035322A1 Selektive Hemmstoffe humaner Corticoidsynthasen Selective inhibitors of human Corticoidsynthasen |
| 02/16/2006 | CA2576254A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 02/16/2006 | CA2575316A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/16/2006 | CA2574827A1 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 02/16/2006 | CA2573857A1 A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step |
| 02/16/2006 | CA2572754A1 Mass tags for quantitative analyses |
| 02/15/2006 | EP1625115A1 Substituted pyrimidine derivatives |
| 02/15/2006 | CN1735614A Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| 02/15/2006 | CN1735607A 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 02/15/2006 | CN1735601A Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 02/15/2006 | CN1735598A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist |
| 02/15/2006 | CN1733758A Imide analog compounds and its preparation method |
| 02/15/2006 | CN1733738A Preparation method of 4-(3-chlor-4-fluorobenzeneamidocyanogen)-7-methoxy-6-(3-morpholine oxypropyl)quinazoline |
| 02/15/2006 | CN1733737A Preparation method of rosuvastain and its salt |
| 02/15/2006 | CN1733736A Azo aryl heterocycle diamines and its preparation method |
| 02/15/2006 | CN1733735A N-2-pyrimidinyl oxy-benzyl substituted cyclic amine compound, its preparation process and uses |
| 02/15/2006 | CN1733734A 4-(p-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-methyl formate synthesis method |
| 02/15/2006 | CN1733730A Iridium compound and organic electroluminescent device using the same |
| 02/15/2006 | CN1241927C Efficient method for refining tetrodotoxin by liquid-phase method |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | US6998368 Wear resistance; oil additive |
| 02/14/2006 | CA2218945C 4-aminoquinazoline derivatives |
| 02/09/2006 | WO2006015382A2 Integrin alpha-v beta-3 antagonists for use in imaging and therapy |
| 02/09/2006 | WO2006014482A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 02/09/2006 | WO2006014207A1 Prostaglandin analogs |
| 02/09/2006 | WO2005118558A3 Pyrimidine compounds and use thereof |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030599 Sulphonamide derivatives |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030575 Such as 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-(3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino- beta -alanine Hydrochloride; for therapy and prophylaxis of disease conditions that are associated with the biological activity of integrin receptors |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
| 02/09/2006 | US20060030560 Pyrimidine compounds |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | CA2573223A1 Aromatic compound |
| 02/09/2006 | CA2573103A1 Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer |
| 02/09/2006 | CA2571937A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 02/09/2006 | CA2571786A1 Prostaglandin analogs |
| 02/08/2006 | EP1623973A1 Platinum complex |